Why and How Much

Supplemental oxygen is used to treat hypoxemia — a low arterial oxygen level — not breathlessness per se. It is titrated to a target oxygen saturation, commonly 94–98% for most acutely ill patients, and a lower 88–92% for patients at risk of carbon dioxide retention. Oxygen is a drug with a dose (the flow rate and delivered concentration) and should be prescribed and monitored, not given indiscriminately.

Delivery Devices

Devices differ in how much oxygen they deliver and how reliably. Low-flow systems such as the nasal cannula are comfortable but deliver a variable concentration that depends on the patient's breathing. Simple and non-rebreather (reservoir) face masks deliver higher concentrations, the non-rebreather being used for critically low oxygen. Venturi masks deliver a precise, fixed concentration, useful when exact control matters, and high-flow nasal cannula provides heated, humidified high-flow oxygen.

The CO2 Retention Risk

In some patients with chronic lung disease who retain carbon dioxide (such as certain COPD patients), giving too much oxygen can worsen hypercapnia and cause respiratory acidosis and depressed consciousness, through mechanisms including altered ventilation-perfusion matching and reduced respiratory drive. These patients are targeted to a lower saturation (88–92%) using controlled oxygen, often via a Venturi mask, with monitoring of blood gases.

Escalation

If a patient remains hypoxemic despite increasing oxygen, or shows rising work of breathing or carbon dioxide, escalation is needed — from low-flow to high-concentration devices, to high-flow nasal cannula, to noninvasive ventilation, and ultimately to intubation and mechanical ventilation. Throughout, the underlying cause of hypoxemia is diagnosed and treated, since oxygen is supportive rather than curative.